Acumen Pharmaceuticals, Inc. (ABOS) Options Statistics & Positioning

Max pain sits at $2.5 and the put/call open interest ratio is 0.24. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$3.08
52-week range
$1.22 – $3.41
IV rank
57 / 100
Moderate
Put/call OI
0.24
Call-heavy
Max pain
$2.5
↓ 18.7% below close
Next earnings
Nov 12, 2026

Most Active ABOS Contracts

ContractExpirationDTELastIVVolume
ABOS $5 call Oct 16, 2026 53d $0.05 0.0% 189
ABOS $2.5 put Sep 18, 2026 25d $0.15 32
ABOS $5 call Dec 18, 2026 116d $0.43 10
ABOS $5 call Jan 15, 2027 144d $0.61 9
ABOS $2.5 call Jan 15, 2027 144d $1.33 3
See all active ABOS contracts →

Explore ABOS Options Statistics

Upcoming Earnings

ABOS's next expected earnings date is Nov 12, 2026.

Explore the payoff profile of option on ABOS for free

Build multi-leg ABOS strategies, visualize payoffs, and scan the full US options universe with OptiView.

ABOS Options FAQ

When is ABOS's next earnings date?

ABOS's next expected earnings date is Nov 12, 2026.

How often is ABOS options data on this page updated?

All ABOS statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see ABOS max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated ABOS pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.